JPS624372B2 - - Google Patents

Info

Publication number
JPS624372B2
JPS624372B2 JP52066368A JP6636877A JPS624372B2 JP S624372 B2 JPS624372 B2 JP S624372B2 JP 52066368 A JP52066368 A JP 52066368A JP 6636877 A JP6636877 A JP 6636877A JP S624372 B2 JPS624372 B2 JP S624372B2
Authority
JP
Japan
Prior art keywords
phytate
solution
calcium chloride
calcium
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52066368A
Other languages
English (en)
Japanese (ja)
Other versions
JPS52151733A (en
Inventor
Andore Nadoo Jatsuku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS52151733A publication Critical patent/JPS52151733A/ja
Publication of JPS624372B2 publication Critical patent/JPS624372B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6636877A 1976-06-07 1977-06-07 Diagnostic kit Granted JPS52151733A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA254,190A CA1053149A (en) 1976-06-07 1976-06-07 Diagnostic kit

Publications (2)

Publication Number Publication Date
JPS52151733A JPS52151733A (en) 1977-12-16
JPS624372B2 true JPS624372B2 (enExample) 1987-01-30

Family

ID=4106144

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6636877A Granted JPS52151733A (en) 1976-06-07 1977-06-07 Diagnostic kit

Country Status (9)

Country Link
JP (1) JPS52151733A (enExample)
BE (1) BE855380A (enExample)
CA (1) CA1053149A (enExample)
CH (1) CH629964A5 (enExample)
DE (1) DE2725666A1 (enExample)
DK (1) DK218877A (enExample)
FR (1) FR2362620A1 (enExample)
GB (1) GB1545024A (enExample)
NL (1) NL7705402A (enExample)

Also Published As

Publication number Publication date
FR2362620A1 (fr) 1978-03-24
JPS52151733A (en) 1977-12-16
FR2362620B1 (enExample) 1980-04-18
DE2725666A1 (de) 1977-12-15
BE855380A (fr) 1977-12-05
CA1053149A (en) 1979-04-24
CH629964A5 (en) 1982-05-28
NL7705402A (nl) 1977-12-09
GB1545024A (en) 1979-05-02
DK218877A (da) 1977-12-08

Similar Documents

Publication Publication Date Title
US3898328A (en) Dry stable composition for the treatment of scours and dehydration
JPH05320052A (ja) 核酸成分組成物
JP5941035B2 (ja) カルシトニンの経口投与
US8263119B2 (en) Capsule formulations containing lanthanum compounds
CN107050433A (zh) 降钙素的口服施用
CN1202110A (zh) 口服抗菌组合物
JPS6133808B2 (enExample)
JP2003508436A (ja) 非経口投与のための医薬として安定なオキザリプラチナム製剤
DE2737932A1 (de) Mittel zur herstellung einer radiodiagnostischen loesung
JPS595123A (ja) 骨格造影に使用する凍結乾燥製品の製造方法
US4070493A (en) Diagnostic kit
US4087516A (en) Body scanning agent
US3891755A (en) Dosage formulation for erythromycin cetyl sulfate
GB2108967A (en) Process for the preparation of colloidal radioisotope carriers from human serum albumin and their use
JPS624372B2 (enExample)
JPS635028A (ja) 凍結乾燥医薬組成物
US3743714A (en) Novel carrier preparations for injectable radioactive compositions
JPS5946229A (ja) 骨格造影に使用する凍結乾燥製品の製造法
JPS5915888B2 (ja) ９９ｍ−テクネチウム標識スズコロイド
US1526981A (en) Effervescent alkali compound and process of manufacturing and preparing the same
EP0096934B1 (en) Radiographic imaging agents
JP4475405B2 (ja) 医薬組成物
CN102988305B (zh) 一种含有环磷腺苷葡胺化合物的药物组合物
JPS62234030A (ja) ｔＰＡ医薬組成物
CN100400106C (zh) 吐温介入的锝-99m异腈类配合物、二步法异腈类药盒及应用